Variant report
Variant | nsv971284 |
---|---|
Chromosome Location | chr8:10539307-10541013 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr8:10539300-10539450 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr8:10540020-10540170 | GM12868 | blood: | n/a | n/a |
3 | CTCF | chr8:10539460-10539610 | NHEK | skin: | n/a | chr8:10539477-10539490 |
4 | CTCF | chr8:10539220-10539370 | HMEC | breast: | n/a | n/a |
5 | CTCF | chr8:10539361-10539426 | Hela-S3 | cervix: | n/a | n/a |
6 | CTCF | chr8:10539340-10539490 | GM12873 | blood: | n/a | chr8:10539477-10539490 |
7 | CTCF | chr8:10539300-10539450 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr8:10539340-10539490 | HUVEC | blood vessel: | n/a | chr8:10539477-10539490 |
9 | CTCF | chr8:10539350-10539429 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr8:10539428-10539437 | Hela-S3 | cervix: | n/a | n/a |
11 | MAZ | chr8:10540694-10540702 | Hela-S3 | cervix: | n/a | n/a |
12 | MAZ | chr8:10540018-10540096 | K562 | blood: | n/a | n/a |
13 | MYC | chr8:10540824-10540832 | NB4 | blood: | n/a | n/a |
14 | NFYA | chr8:10539142-10539433 | Hela-S3 | cervix: | n/a | n/a |
15 | POLR2A | chr8:10539326-10539373 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr8:10539440-10539477 | MCF-7 | breast: | n/a | n/a |
17 | POLR2A | chr8:10539736-10540213 | HL-60 | blood: | n/a | n/a |
18 | POLR2A | chr8:10539382-10539392 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr8:10539089-10539314 | MCF-7 | breast: | n/a | n/a |
20 | POLR2A | chr8:10540330-10540419 | HUVEC | blood vessel: | n/a | n/a |
21 | POLR2A | chr8:10539489-10539497 | MCF-7 | breast: | n/a | n/a |
22 | SMARCB1 | chr8:10538005-10539526 | Hela-S3 | cervix: | n/a | n/a |
23 | SMARCC1 | chr8:10538014-10539660 | Hela-S3 | cervix: | n/a | n/a |
24 | SPI1 | chr8:10539895-10540139 | K562 | blood: | n/a | n/a |
25 | SPI1 | chr8:10539756-10540240 | HL-60 | blood: | n/a | n/a |
26 | SPI1 | chr8:10539861-10540074 | GM12878 | blood: | n/a | n/a |
27 | SPI1 | chr8:10539839-10540201 | HL-60 | blood: | n/a | n/a |
28 | TCF7L2 | chr8:10537996-10539397 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:10537022..10539383-chr8:10695484..10697412,2 | K562 | blood: | |
2 | chr8:10539212..10541927-chr8:10542466..10544181,2 | K562 | blood: | |
3 | chr8:10539212..10540819-chr8:10542466..10545338,2 | K562 | blood: | |
4 | chr8:10535340..10537589-chr8:10540581..10542267,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP252 | TF binding region |
ENSG00000212433 | chromatin interactions |
ENSG00000258724 | chromatin interactions |
ENSG00000254093 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184722237 | chr8:10539307-10539308 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs549930680 | chr8:10539321-10539322 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs188058589 | chr8:10539324-10539325 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs143563907 | chr8:10539329-10539330 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs548718031 | chr8:10539332-10539333 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs555351659 | chr8:10539343-10539344 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs565630049 | chr8:10539344-10539345 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs35793804 | chr8:10539352-10539353 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554083822 | chr8:10539359-10539360 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs577116651 | chr8:10539366-10539367 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs539671115 | chr8:10539376-10539377 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs114441426 | chr8:10539387-10539388 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs373676687 | chr8:10539391-10539392 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs112013180 | chr8:10539412-10539413 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs59080221 | chr8:10539441-10539442 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs114866773 | chr8:10539477-10539478 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs541436416 | chr8:10539510-10539511 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs564403300 | chr8:10539516-10539517 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs367819756 | chr8:10539607-10539608 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs533249571 | chr8:10539631-10539632 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs556897025 | chr8:10539643-10539644 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs549725236 | chr8:10539674-10539675 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs192244020 | chr8:10539680-10539681 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs11989988 | chr8:10539684-10539685 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs549022260 | chr8:10539695-10539696 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559976715 | chr8:10539715-10539716 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs148657097 | chr8:10539740-10539741 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs528120600 | chr8:10539746-10539747 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs550938985 | chr8:10539767-10539768 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs570842076 | chr8:10539793-10539794 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs539707868 | chr8:10539803-10539804 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs556498580 | chr8:10539825-10539826 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs570194966 | chr8:10539830-10539831 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs372131037 | chr8:10539915-10539916 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs535665355 | chr8:10539921-10539922 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs375487240 | chr8:10539926-10539927 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs555878529 | chr8:10539949-10539950 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs142175575 | chr8:10539956-10539957 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs185833861 | chr8:10539960-10539961 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs558150081 | chr8:10539967-10539968 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs578016372 | chr8:10539999-10540000 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs553166337 | chr8:10540037-10540038 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs573343223 | chr8:10540052-10540053 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs189181278 | chr8:10540130-10540131 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs529127001 | chr8:10540141-10540142 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs151211571 | chr8:10540160-10540161 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs371458102 | chr8:10540175-10540176 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs542541318 | chr8:10540187-10540188 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs559048387 | chr8:10540196-10540197 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs77419999 | chr8:10540199-10540200 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Gastric cancer | 21811585 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:10536200-10540600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr8:10536800-10541800 | Enhancers | Spleen | Spleen |
3 | chr8:10537000-10542000 | Enhancers | Esophagus | oesophagus |
4 | chr8:10537600-10539400 | Enhancers | HUVEC | blood vessel |
5 | chr8:10537600-10539600 | Enhancers | Gastric | stomach |
6 | chr8:10538000-10539400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr8:10538000-10539400 | Enhancers | HMEC | breast |
8 | chr8:10538000-10539600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr8:10538000-10539800 | Enhancers | Lung | lung |
10 | chr8:10538200-10540200 | Enhancers | Pancreas | Pancrea |
11 | chr8:10539000-10539400 | Bivalent Enhancer | Right Ventricle | heart |
12 | chr8:10539000-10542800 | Weak transcription | Liver | Liver |
13 | chr8:10539200-10539400 | Enhancers | Stomach Mucosa | stomach |
14 | chr8:10539200-10539600 | Enhancers | A549 | lung |
15 | chr8:10539200-10540200 | Enhancers | Hela-S3 | cervix |
16 | chr8:10539400-10540400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr8:10539400-10541400 | Weak transcription | HUVEC | blood vessel |
18 | chr8:10540200-10541400 | Weak transcription | Pancreas | Pancrea |
19 | chr8:10540400-10541000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr8:10540800-10541600 | Enhancers | Lung | lung |
21 | chr8:10541000-10547400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |